HER2 Positive Solid Tumors
Also known as: HER2-Positive Solid Tumors / HER2 Positive Solid Tumor / HER2-positive Solid Tumor
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18411 | Anbenitamab | 1 | Completed | 1 |
| DB11595 | Atezolizumab | 1 | Completed | 1 |
| DB01101 | Capecitabine | 1 | Recruiting | 1 |
| DB14707 | Cemiplimab | 1 | Active Not Recruiting | 1 |
| DB18402 | Cinrebafusp alfa | 1 | Completed | 2 |
| DB17446 | Erfonrilimab | 1 | Completed | 1 |
| DB08871 | Eribulin | 1 | Recruiting | 1 |
| DB00544 | Fluorouracil | 1 | Recruiting | 1 |
| DB00650 | Leucovorin | 1 | Recruiting | 1 |
| DB00526 | Oxaliplatin | 1 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 2 |
| DB15043 | Toripalimab | 1 | Recruiting | 1 |
| DB00072 | Trastuzumab | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
| DB18411 | Anbenitamab | 2 | Completed | 1 |
| DB17446 | Erfonrilimab | 2 | Completed | 1 |
| DB00072 | Trastuzumab | 2 | Withdrawn | 1 |